Prevalence of intraocular tumours detected by ultrasonography in eyes with opaque media

Published:October 13, 2022DOI:



      To study the prevalence of intraocular tumours detected by screening ultrasonography in eyes with opaque media.


      Retrospective review of B-scan ultrasonography in eyes with opaque media and diagnosis of blindness or phthisis between January 1, 1994, and December 31, 2013. Ultrasounds for diagnostic purposes in acute endophthalmitis, retinal detachment, or vitreous hemorrhage were excluded.


      There were 119 blind eyes with opaque media examined with B-scan ultrasonography. Mean patient age was 59 years, with visual acuity of hand motions or worse in 89 eyes (74.8%), elevated intraocular pressure in 23 eyes (19.3%), and pain in 30 eyes (25.4%). Follow-up was ≥1 year in 69 eyes (58%) with a mean 64 months (median, 56 months; range, 12–129 months). Of these 69 eyes, ultrasound frequency was more often than annual in 2 eyes (2.9%), annual in 2 eyes (2.9%), every 13–60 months in 43 eyes (62%), every 61–120 months in 19 eyes (27.5%), and less often than every 120 months in 3 eyes (4.3%). Sixteen eyes with opaque media only received ultrasound at presentation, and 6 eyes had screening ultrasonography only prior to evisceration or enucleation. No intraocular tumours were detected in any eye during the study period.


      In this series, no intraocular tumours were detected by screening ultrasonography in eyes with opaque media. Larger studies with long-term follow-up are required to determine the utility and cost-effectiveness of serial ultrasonography monitoring. Ultrasound may have its highest utility in the setting of initial evaluation, clinical change, and preoperative work-up to avoid evisceration in the setting of occult malignancy.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Canadian Journal of Ophthalmology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Edelstein C
        • Shields CL
        • Shields JA
        • Eagle Jr., RC
        Presumed adenocarcinoma of the retinal pigment epithelium in a blind eye with a staphyloma.
        Arch Ophthalmol. 1998; 116: 525-528
        • Loeffler KU
        • Kivela T
        • Borgmann H
        • Witschel H.
        Malignant tumor of the retinal pigment epithelium with extraocular extension in a phthisical eye.
        Graefes Arch Clin Exp Ophthalmol. 1996; 234: S70-S75
        • Pereira PR
        • Odashiro AN
        • Souza Filho JP
        • et al.
        Malignancy in the blind painful eye: report of two cases and literature review.
        Diagn Pathol. 2006; 1: 45
        • Sarma DP
        • Deshotels Jr, SJ
        • Lunseth JH.
        Malignant melanoma in a blind eye.
        J Surg Oncol. 1983; 23: 169-172
        • Tripathi A
        • Hiscott P
        • Damato BE.
        Malignant melanoma and massive retinal gliosis in phthisis bulbi.
        Eye (Lond). 2002; 16: 781-782
        • Escalona-Benz E
        • Benz MS
        • Briggs JW
        • et al.
        Uveal melanoma presenting as acute angle-closure glaucoma: report of two cases.
        Am J Ophthalmol. 2003; 136: 756-758
        • O'Leary SW
        • Ramsey MS.
        Unsuspected uveal melanoma diagnosed after cataract extraction.
        Can J Ophthalmol. 1990; 25: 333-335
        • Eagle Jr, RC
        • Grossniklaus HE
        • Syed N
        • et al.
        Inadvertent evisceration of eyes containing uveal melanoma.
        Arch Ophthalmol. 2009; 127: 141-145
        • Zimmerman LE.
        Problems in the diagnosis of malignant melanomas of the choroid and ciliary body. The 1972 Arthur J. Bedell Lecture.
        Am J Ophthalmol. 1973; 75: 917-929
        • Makley Jr, TA
        • Teed RW.
        Unsuspected intraocular malignant melanomas.
        AMA Arch Ophthalmol. 1958; 60: 475-478
        • Mundt Jr, GH
        • Hughes Jr., WF
        Ultrasonics in ocular diagnosis.
        Am J Ophthalmol. 1956; 41: 488-498
        • Atta HR.
        New applications in ultrasound technology.
        Br J Ophthalmol. 1999; 83: 1246-1249
        • Litricin O.
        Unsuspected uveal melanomas.
        Am J Ophthalmol. 1973; 76: 734-738
        • Shields CL
        • Pellegrini M
        • Kligman BE
        • et al.
        Ciliary body and choroidal pseudomelanoma from ultrasonographic imaging of hypermature cataract in 20 cases.
        Ophthalmology. 2013; 120: 2546-2551
        • Shields JA
        • McDonald PR
        • Leonard BC
        • Canny CL.
        The diagnosis of uveal malignant melanomas in eyes with opaque media.
        Am J Ophthalmol. 1977; 83: 95-105
        • Bakri SJ
        • Sculley L
        • Singh AD.
        Imaging techniques for uveal melanoma.
        Int Ophthalmol Clin. 2006; 46: 1-13
        • Singh AD
        • Turell ME
        • Topham AK.
        Uveal melanoma: trends in incidence, treatment, and survival.
        Ophthalmology. 2011; 118: 1881-1885